Sunday, June 28, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Lockheed Martin Stock: Record Defense Contract Signals New Growth Phase

Dieter Jaworski by Dieter Jaworski
September 14, 2025
in Analysis, Defense & Aerospace, Mergers & Acquisitions
0
Lockheed Stock
0
SHARES
160
VIEWS
Share on FacebookShare on Twitter

Defense titan Lockheed Martin is experiencing an unprecedented surge in contract awards, positioning the corporation for significant expansion. A landmark $9.8 billion agreement with the U.S. Army and a freshly announced strategic collaboration with BAE Systems are propelling the firm to new heights. Despite management’s bullish growth projections, the company’s shares have shown notable volatility, prompting investors to question whether this marks the start of a sustained upward cycle or if current valuations already reflect these positive developments.

Strategic Alliance and Military Contracts Drive Expansion

Lockheed Martin’s recent strategic movements present a compelling growth narrative. On September 9th, the company revealed a pioneering partnership between its Skunk Works division and BAE Systems’ FalconWorks unit at the DSEI exhibition in London. This collaboration focuses on developing next-generation defense technologies and establishes a more resilient global industrial network, potentially unlocking substantial international market opportunities. Company leadership expressed particular optimism about their international business segment, forecasting growth rates that could match or exceed domestic performance.

The corporation’s momentum continued with a monumental contract announcement on September 3rd. Lockheed secured the largest single order in its Missiles and Fire Control division’s history—a $9.8 billion agreement to supply 1,970 PAC-3 MSE Patriot missiles to the U.S. Army between 2024 and 2026. The significance of this deal was underscored by ceremonial events in Grand Prairie, Texas.

Simultaneously, Lockheed’s joint venture with RTX Corporation captured an additional $900.5 million contract for Javelin missiles, notably expanding its customer base to include nations in South America and North Africa for the first time. Major General Frank Lozano highlighted the mutual benefits of this multi-year procurement strategy, emphasizing increased volume, accelerated delivery timelines, and improved pricing for all parties involved.

Financial Outlook and Market Positioning

During the Morgan Stanley conference on September 11th, CEO Jim Taiclet and CFO Evan Scott presented an ambitious financial roadmap backed by a formidable $167 billion order backlog. Their projections include 4-5% revenue growth for 2025, with cash flow metrics that will undoubtedly appeal to shareholders:
– 2025 free cash flow target: $6.7 billion
– 2026 free cash flow target: $7 billion
– Planned shareholder returns: $6 billion equally allocated between dividend payments and share repurchases

Should investors sell immediately? Or is it worth buying Lockheed?

The F-35 production program remains a cornerstone of stability, maintaining output of 156 units annually amid robust global demand.

Favorable Defense Spending Environment

The company’s strategic positioning aligns perfectly with expanding global defense budgets. The Pentagon’s proposed 2026 modernization budget includes a more than 20% increase, benefiting multiple Lockheed Martin divisions. The Navy’s programming of PAC-3 ammunition and additional funding for hypersonic technology initiatives create further tailwinds.

Despite some program-related challenges in the second quarter, management has reaffirmed its full-year guidance. All eyes now turn to the Q3 earnings release scheduled for October 28th, where market experts anticipate earnings per share of $6.33.

With record contracts and strategic partnerships consolidating its market position, Lockheed Martin appears exceptionally well-positioned to capitalize on the ongoing global defense expansion. In an increasingly volatile geopolitical landscape, demand for advanced weapon systems shows no signs of diminishing.

Ad

Lockheed Stock: Buy or Sell?! New Lockheed Analysis from June 28 delivers the answer:

The latest Lockheed figures speak for themselves: Urgent action needed for Lockheed investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from June 28.

Lockheed: Buy or sell? Read more here...

Tags: Lockheed
Dieter Jaworski

Dieter Jaworski

About Dieter Jaworski From a numbers-obsessed child to creating his first investment newsletter. Even as a child, Dieter Jaworski's mother couldn't believe how fascinated he was with numbers. This early passion for mathematics and data analysis laid the foundation for a successful career in financial markets and investment analysis.
Areas of Expertise:
  • Quantitative Analysis
  • Financial Newsletter Publishing
  • Data-Driven Investment Strategies
  • Market Pattern Recognition
Dieter's unique approach combines his natural affinity for numbers with decades of market experience, providing investors with data-driven insights and practical investment strategies.

Related Posts

Hensoldt Stock
Defense & Aerospace

Hensoldt’s €63 Support Holds the Key After F126 Collapse Triggers 24% Rout

June 28, 2026
Deutsche Telekom Stock
DAX

Deutsche Telekom: Nearing Its 52-Week Low, the Stock Loses a Key Buyer Just as Merger Speculation Intensifies

June 28, 2026
CSG Stock
Analysis

CSG Shares Bounce from €12.20 Low, but Short Seller Cloud Hangs Over €17B Order Book Ahead of Results

June 28, 2026
Next Post
Rockwell Automation Stock

Institutional Giants Bet Big on Industrial Automation Leader

Stratus Properties Stock

Stratus Properties Stock: A Turnaround Story Gains Momentum

Protagonist Therapeutics Stock

Protagonist Therapeutics Advances Key Drug Candidate with European Regulatory Submission

Recommended

Gladstone Capital Stock

Income Investors Face Setback as Gladstone Capital Reduces Dividend Payout

9 months ago
Ford Stock

Ford Bets Big on India Expansion Amid Electric Vehicle Setbacks

8 months ago
Microsoft Stock

Microsoft’s Strategic Pivot: Navigating the Windows Transition While Accelerating AI Dominance

9 months ago
Xiaomi Stock

Xiaomi’s Dual AI Announcements Spark Investor Interest Amid Ongoing Challenges

4 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

DroneShield’s $730M Catalyst Looms as ASIC Probe Overshadows a 121% Revenue Surge

Dividend Hunters Flock to VanEck’s Rules-Based ETF as €2.1bn Inflow Sparks New Accumulating Share Class

Thyssenkrupp’s Restructuring Crossroads: Shareholders to Decide on Spin-Off After Week of Setbacks

For Keel Infrastructure, the Russell 3000 Spot Is Just the Prologue to a Lease-Driven Narrative

Partners Group Stock Trades Near 52-Week Low as Evergreen Pressure Meets a $220 Million Miami Bet

AMD’s 140% Surge Meets the ‘Jalapeño’ Test: Why the Next Move Isn’t About Chips Anymore

Trending

Hensoldt Stock
Defense & Aerospace

Hensoldt’s €63 Support Holds the Key After F126 Collapse Triggers 24% Rout

by Kennethcix
June 28, 2026
0

The steep sell-off in Hensoldt shares has brought the defence electronics group's 52-week low within touching distance,...

Deutsche Telekom Stock

Deutsche Telekom: Nearing Its 52-Week Low, the Stock Loses a Key Buyer Just as Merger Speculation Intensifies

June 28, 2026
CSG Stock

CSG Shares Bounce from €12.20 Low, but Short Seller Cloud Hangs Over €17B Order Book Ahead of Results

June 28, 2026
DroneShield Stock

DroneShield’s $730M Catalyst Looms as ASIC Probe Overshadows a 121% Revenue Surge

June 28, 2026
VanEck Morningstar Developed Markets Dividend Leaders UCITS ETF Stock

Dividend Hunters Flock to VanEck’s Rules-Based ETF as €2.1bn Inflow Sparks New Accumulating Share Class

June 28, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Hensoldt’s €63 Support Holds the Key After F126 Collapse Triggers 24% Rout
  • Deutsche Telekom: Nearing Its 52-Week Low, the Stock Loses a Key Buyer Just as Merger Speculation Intensifies
  • CSG Shares Bounce from €12.20 Low, but Short Seller Cloud Hangs Over €17B Order Book Ahead of Results

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com